Company intelligence / Profile preview
Cidara Therapeutics
San Diego, California, United Statescidara.com ↗
- Ownership
- Public · CDTX
- Development stage
- Other
01
Overview
The company’s lead candidate, CD388, a long-lasting antiviral targeting universal influenza prevention, completed enrollment of a large Phase 2b NAVIGATE trial with potential early efficacy data expected mid-year 2025. The oncology candidate CBO421 received IND clearance in July 2024 to target solid tumors expressing CD73. Additional programs are at earlier stages.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Drug-Fc conjugates (DFCs)Small molecules (as payloads in DFCs)Peptides (as payloads in DFCs)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Johnson & Johnson/Janssen Pharmaceuticals – previous collaboration on influenza therapy rights; reacquired by Cidara in April 2024WuXi XDC – chemistry/manufacturing services for oncology programNapp Pharmaceutical Group Limited/Mundipharma – divestiture agreement for rezafungin asset
Beyond the preview
Go deeper on Cidara Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cidara Therapeutics.